AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.100
+0.040 (3.77%)
Feb 27, 2026, 4:00 PM EST - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $30.14 million as of February 27, 2026. Its market cap has decreased by -7.45% in one year.
Market Cap
30.14M
Enterprise Value
-31.78M
1-Year Change
-7.45%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $30.14M, a decrease of -89.28%. That is a compound annual growth rate of -43.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 30.14M | -3.51% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 32.36M |
| ABVC BioPharma | 32.35M |
| Lantern Pharma | 31.54M |
| Tempest Therapeutics | 30.74M |
| NeuroSense Therapeutics | 30.35M |
| Rein Therapeutics | 29.97M |
| Werewolf Therapeutics | 29.13M |
| Passage Bio | 28.99M |